The Vanguard Group Discloses Position in Spire Healthcare Group

The Vanguard Group, Inc. has submitted a Form 8.3 regarding its stake in Spire Healthcare Group plc. As of August 11, 2026, Vanguard possesses 14,308,251 ordinary shares, representing 3.55% of Spire's outstanding securities. This disclosure aligns with Rule 8.3 of the Takeover Code, which mandates transparency for entities holding 1% or more in relevant security interests.

Additionally, Vanguard declared a recent purchase of 11,386 ordinary shares at a price of 2.30 GBP per share. The form confirms that Vanguard has no outstanding stock-settled derivative positions or related agreements, and no new security subscriptions were executed. There are no existing agreements or arrangements impacting voting rights or future transactions involving derivatives.